AstraZeneca says to invest $50 bn in the US / Photo: Jonathan NACKSTRAND - AFP/File
-
Kenya's economy faces climate change risks: World Bank
-
Greece aims to cut queues at ancient sites with new portal
-
ECB holds interest rates as strong euro causes jitters
-
What does Iran want from talks with the US?
-
Wind turbine maker Vestas sees record revenue in 2025
-
Bitcoin under $70,000 for first time since Trump's election
-
Germany claws back 59 mn euros from Amazon over price controls
-
Germany claws back 70 mn euros from Amazon over price controls
-
Stock markets drop amid tech concerns before rate calls
-
BBVA posts record profit after failed Sabadell takeover
-
UN human rights agency in 'survival mode': chief
-
Greenpeace slams fossel fuel sponsors for Winter Olympics
-
Russia says thwarted smuggling of giant meteorite to UK
-
Heathrow still Europe's busiest airport, but Istanbul gaining fast
-
Shell profits climb despite falling oil prices
-
German factory orders rise at fastest rate in 2 years in December
-
Trump fuels EU push to cut cord with US tech
-
Top US news anchor pleads with kidnappers for mom's life
-
The coming end of ISS, symbol of an era of global cooperation
-
New crew set to launch for ISS after medical evacuation
-
Stocks in retreat as traders reconsider tech investment
-
Fiji football legend returns home to captain first pro club
-
Barry Manilow cancels Las Vegas shows but 'doing great' post-surgery
-
Rising euro, falling inflation in focus at ECB meeting
-
AI to track icebergs adrift at sea in boon for science
-
Google's annual revenue tops $400 bn for first time, AI investments rise
-
Boxer Khelif reveals 'hormone treatments' before Paris Olympics
-
BHP damages trial over Brazil mine disaster to open in 2027
-
Bezos-led Washington Post announces 'painful' job cuts
-
UK PM says Mandelson 'lied' about Epstein relations
-
Trump suggests 'softer touch' needed on immigration
-
Panama hits back after China warns of 'heavy price' in ports row
-
US seeks minerals trade zone in rare Trump move with allies
-
US removing 700 immigration officers from Minnesota
-
Son of Norway's crown princess admits excesses but denies rape
-
Netflix film probes conviction of UK baby killer nurse
-
Sales warning slams Ozempic maker Novo Nordisk's stock
-
GSK boosted by specialty drugs, end to Zantac fallout
-
UK's ex-prince leaves Windsor home amid Epstein storm: reports
-
Stocks swing following latest AI-fuelled sell-off on Wall St
-
Whack-a-mole: US academic fights to purge his AI deepfakes
-
UBS grilled on Capitol Hill over Nazi-era probe
-
NASA Moon mission launch delayed to March after test
-
EU must be 'less naive' in COP climate talks: French ministry
-
Air India inspects Boeing 787 fuel switches after grounding
-
Four out of every 10 cancer cases are preventable: WHO
-
Eswatini minister slammed for reported threat to expel LGBTQ pupils
-
Pfizer shares drop on quarterly loss
-
Germany acquires power grid stake from Dutch operator
-
Germany has highest share of older workers in EU
NYSE - LSE
| RBGPF | 0.12% | 82.5 | $ | |
| SCS | 0.12% | 16.14 | $ | |
| BCC | 0.31% | 90.51 | $ | |
| GSK | 3.18% | 59.11 | $ | |
| RIO | -3.4% | 93.31 | $ | |
| CMSD | -0.04% | 23.86 | $ | |
| RYCEF | -0.36% | 16.62 | $ | |
| CMSC | 0.34% | 23.6 | $ | |
| BCE | -3.76% | 25.385 | $ | |
| NGG | -1.35% | 86.62 | $ | |
| AZN | 1.33% | 189.985 | $ | |
| JRI | 1.09% | 13.295 | $ | |
| VOD | -6.26% | 14.785 | $ | |
| BTI | 0.75% | 62.095 | $ | |
| RELX | 2.41% | 30.515 | $ | |
| BP | -2.23% | 38.345 | $ |
AstraZeneca says to invest $50 bn in the US
British pharmaceutical giant AstraZeneca said Tuesday it would invest $50 billion in the United States amid a looming deadline of ramped-up tariffs from Washington.
A large chunk of the funds will go toward building a multi-billion-dollar manufacturing centre in Virginia, the company said in a statement, adding that it expects 50 percent of its revenue to come from the United States by 2030.
"Today’s announcement underpins our belief in America’s innovation in biopharmaceuticals," the statement quoted CEO Pascal Soriot as saying.
US President Donald Trump has opened the door to potential tariffs targeting pharmaceuticals, which have so far benefited from exemptions to his sweeping levies on imports from trading partners.
He ordered an investigation launched into pharmaceutical imports, suggesting that levies could reach up to 200 percent.
The United States is a key market for the pharmaceutical industry, and AstraZeneca had already announced in April that it had begun transferring part of its European production to the United States.
"For decades Americans have been reliant on foreign supply of key pharmaceutical products," US Commerce Secretary Howard Lutnick said in a statement.
He added that the new tariffs are focused on "ending this structural weakness".
The announcement included a new factory in Virginia, which will be the company's "largest single manufacturing investment".
Other major pharmaceutical companies, which had been exempt from tariffs for 30 years, have, in recent months, begun shifting investment and production to the United States.
D.Philippon--CPN